Status:
COMPLETED
SPME For Metabolomics And Concomitant Measurements Of Rocuronium Bromide Levels In Liver Transplantation
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
University of Waterloo
Conditions:
Liver Failure
Eligibility:
All Genders
18+ years
Brief Summary
Standard anesthetic management of liver transplantation patients includes a general anesthetic using multiple drugs, including the neuromuscular relaxant rocuronium. Pharmacokinetic modelling of this ...
Eligibility Criteria
Inclusion
- First time liver transplant recipients above 18 years of age
- Elective cadaveric or living donor liver transplant patients will be recruited
Exclusion
- All patients under 18 years of age
- Unable to give consent
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01404793
Start Date
September 1 2011
End Date
April 1 2015
Last Update
April 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada